(S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate

CAS1201180-97-3

(S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate (CAS 1201180-97-3) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate
CAS No.
1201180-97-3

Chemical Specifications

Identifiers

CAS number 1201180-97-3
Product name (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate
Chinese name 5-[(2S)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈-D-(-)-酒石酸盐

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate?

The CAS Registry Number of (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate is 1201180-97-3.

How can I request a quotation for (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate?

Send an inquiry for (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate (CAS 1201180-97-3) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.